Therakos is now a part of Mallinckrodt Pharmaceuticals.
Medical DevicesPennsylvania, United States5001-10000 Employees
Therakos operates as a medical equipment manufacturing entity that is now part of Mallinckrodt Pharmaceuticals, based in West Chester, Pennsylvania. The business sits within Mallinckrodt’s global specialty biopharmaceutical and medical imaging footprint, developing, manufacturing, marketing and distributing specialty pharmaceutical products and imaging agents. Its focus includes therapies for autoimmune and rare diseases across neurology, rheumatology, nephrology and pulmonology, along with analgesics and central nervous system drugs prescribed by office- and hospital-based physicians. This work is supported by the parent company’s strengths in managing regulated raw materials, regulatory expertise and specialized chemistry, formulation and manufacturing capabilities. Therakos targets healthcare providers managing complex autoimmune and rare-disease treatment needs, with a distribution and practice-facing model typical of the broader specialty pharmaceutical and imaging space. The organization aligns with Mallinckrodt’s three-segment portfolio—Specialty Brands, Specialty Generics and Global Medical Imaging—to serve its customers. In 2026, Therakos entered a three-year educational collaboration with ESOT to advance knowledge exchange through webinars, workshops and research initiatives.